The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma

NCT00270101 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia
Multiple Myeloma

Interventions

DRUG: epoetin alfa

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.